
Colistin (Polymyxin E) Inhalation Solution (Nebulizer) Suppliers & Bulk Manufacturers
Available Forms: Inhalation Solution (Nebulizer)
Available Strengths: 75 mg/2 mL
Reference Brands: Coly-Mycin M(US)
Category: Antibiotics
Colistin (Polymyxin E) Inhalation Solution (Nebulizer) is available in Inhalation Solution (Nebulizer) and strengths such as 75 mg/2 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Colistin (Polymyxin E) Inhalation Solution (Nebulizer) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Colistin (Polymyxin E) Inhalation Solution (Nebulizer) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Colistin (Polymyxin E) inhalation solution is approved in the EU and US for treating Pseudomonas aeruginosa lung infections in cystic fibrosis patients. In Europe, brands like Colobreathe are regulated by EMA, supported by dossiers on safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, with generic options available. Both regions require detailed dossiers, including clinical trial results, quality practices, and pharmacovigilance plans for approval and safety monitoring. Due to its specialized pulmonary use, strict regulations on dosing, storage, and safety follow. For expert regulatory support and seamless market entry, visit PharmaTradz. We ensure compliance with European and US standards for safe, effective inhalation therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Phenoxymethylpenicillin Potassium
Strength:
250 mg, 500 mg, 125 mg/5 mL, 250 mg/5 mL
Form: Tablets / Oral solution
Reference Brands: Pen-Vee K (USA), Betapen-VK (EU)
View DetailsSulfathiazole Cream
Strength:
5%
Form: Ointment
Reference Brands: Generic formulations marketed under different names
View DetailsCefradine
Strength:
250 mg, 500 mg
Form: Tablets
Reference Brands: Velosef (USA/EU), Intracef (EU)
View DetailsDaptomycin
Strength:
350 mg, 500 mg
Form: Injection
Reference Brands: Cubicin (USA/EU), Dapzura RT (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers